Expression of Urokinase-Type Plasminogen Activator Receptor in Paroxysmal Nocturnal Hemoglobinuria and Its Clinical Implications

董孝嫒,徐从高,孙国瑞,张锑,彭军

DOI: https://doi.org/10.3969/j.issn.1671-7554.2004.04.011

2004-01-01

Abstract:Objective: To investigate the expression of urokinase-type plasminogen activator receptor (u-PAR, CD87) on the peripheral blood granulocytes and the soluble u-PAR (su-PAR) level in serum from patients with paroxysmal nocturnal hemoglobinuria (PNH) and to analyze its clinical implications. Methods: Twenty-two patients with PNH, 20 patients with simple thrombosis and 20 healthy volunteers were included in this study. The expression of CD87 on peripheral blood granulocytes were analyzed with flow cytometry. Serum su-PAR was assayed by enzyme-linked immunoadsorbent assay (ELISA). Results: All the fraction of CD87+ granulocytes in peripheral blood of 20 healthy volunteers was more than 90%. The expression of CD87 in 22 patients with PNH decreased significantly and the level of serum su-PAR increased. In the 22 patients with PNH, the fraction of CD87+ granulocytes decreased significantly and the serum level of su-PAR elevated significantly in patients with thrombosis than in patients without thrombosis. The serum level of su-PAR was negatively correlated to the percentage of CD87+ granulocytes in patients with PNH. Conclusion: In patients with PNH, the expression of CD87 in granulocytes decreases remarkably and the serum level of su-PAR increases significantly. Flow cytometric analysis of CD87 on the peripheral blood granulocytes and detection of su-PAR are of value in diagnosis of PNH and helpful for monitoring thrombosis.